I3Archive provides data and image distribution
I3Archive specializes in cross-enterprise distribution and access of health images and data, using distributed archiving supercomputer technology. Its National Digital Medical Archive (NDMA) is a distributed database system currently containing approximately 500,000 digital mammography (and related) DICOM images, associated demographic and clinical data, and reports. The product's name was changed from National Digital Mammography Archive in May to reflect its inclusion of breast MRI and breast ultrasound images.
I3Archive specializes in cross-enterprise distribution and access of health images and data, using distributed archiving supercomputer technology. Its National Digital Medical Archive (NDMA) is a distributed database system currently containing approximately 500,000 digital mammography (and related) DICOM images, associated demographic and clinical data, and reports. The product's name was changed from National Digital Mammography Archive in May to reflect its inclusion of breast MRI and breast ultrasound images.
Although each client's data are securely segregated, NDMA is optimized for authorized healthcare organizations to share applications and storage. With appropriate authorizations, a patient's file originating at one hospital can be accessed and viewed within 90 seconds by another NDMA client. Similarly, data for research can be anonymized and shared by multiple authorized organizations. Permission to transport records from one client to another is highly controlled by multilevel hierarchical permission tables that allow organizations to block or enable other entities' accessibility to content. NDMA is specifically designed to provide analytical databases and reporting systems for research applications in breast cancer. The service includes CAD analysis.
NDMA is offered with three levels of service: NDMA Services provide offsite redundant secure storage, NDMA Onsite adds onsite storage of, typically, up to three years' exams, and NDMA Direct provides access to archived images and reports without the need for additional equipment. All services are customizable.
I3Archive does not provide storage backup-only services, but it will provide disaster recovery services. The company introduced my NDMA.com in February, a service that provides centralized management and archiving of mammography reports and images to individuals.
IBM and GE Healthcare, as well as I3Archive, market and sell NDMA services, although I3Archive directly handles installation. Service is performed through remote monitoring, and a four-hour onsite service response is guaranteed.
What a New Mammography Study Reveals About BMI, Race, Ethnicity and Advanced Breast Cancer Risk
December 8th 2023In a new study examining population attributable risk proportions (PARPs) based on data from over three million screening mammography exams, researchers found that postmenopausal Black women had the highest BMI-related PARP and premenopausal Asian and Pacific Islander women had the highest breast density-related PARP for advanced breast cancer.
What a New Study Reveals About Adjunctive DBT and Early-Stage Invasive Breast Cancer
December 6th 2023The combination of digital breast tomosynthesis (DBT) and digital mammography had a 21.6 higher invasive breast cancer detection rate for stage 1 tumors than digital mammography alone, according to a new study involving nearly 100,000 women.
Study: Regular Mammography Screening Reduces Breast Cancer Mortality Risk by More than 70 Percent
November 30th 2023Consistent adherence to the five most recent mammography screenings prior to a breast cancer diagnosis reduced breast cancer death risk by 72 percent in comparison to women who did not have the mammography screening, according to new research findings presented at the annual Radiological Society of North America (RSNA) conference.
Study Says Contrast-Enhanced Mammography Offers Comparable Breast Cancer Detection to MRI
November 15th 2023In findings from an enriched cohort of asymptomatic patients with screening-detected abnormalities, researchers found that contrast-enhanced mammography (CEM) was superior to conventional mammography and offered equivalent detection of breast cancer in comparison to breast MRI and abbreviated breast MRI.
